Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Dopaminergic Therapy for Frontotemporal Dementia Patients: an Interventional, Multi-site, Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of RTG Treatment in Patients with Behavioral FTD

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04937452
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:06.532745+00:00
Published At
2024-10-22T00:00:00+00:00
Record Updated At
2024-10-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Frontotemporal Dementia", "Dementia", "Aphasia, Primary Progressive", "Pick Disease of the Brain", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Neurocognitive Disorders", "Mental Disorders", "Neurodegenerative Diseases", "Frontotemporal Lobar Degeneration", "TDP-43 Proteinopathies", "Proteostasis Deficiencies", "Metabolic Disease", "Aphasia", "Speech Disorders", "Language Disorders", "Communication Disorders", "Neurobehavioral Manifestations", "Neurologic Manifestations"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-10-22"
protocolSection.identificationModule.nctId
"NCT04937452"
protocolSection.identificationModule.officialTitle
"Dopaminergic Therapy for Frontotemporal Dementia Patients: an Interventional, Multi-site, Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of RTG Treatment in Patients with Behavioral FTD"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Frontotemporal Dementia (protocolSection.conditionsModule.conditions)
  • Dementia (protocolSection.conditionsModule.conditions)
  • Aphasia, Primary Progressive (protocolSection.conditionsModule.conditions)
  • Pick Disease of the Brain (protocolSection.conditionsModule.conditions)
  • Brain Diseases (protocolSection.conditionsModule.conditions)
  • Central Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Neurocognitive Disorders (protocolSection.conditionsModule.conditions)
  • Mental Disorders (protocolSection.conditionsModule.conditions)
  • Neurodegenerative Diseases (protocolSection.conditionsModule.conditions)
  • Frontotemporal Lobar Degeneration (protocolSection.conditionsModule.conditions)
  • TDP-43 Proteinopathies (protocolSection.conditionsModule.conditions)
  • Proteostasis Deficiencies (protocolSection.conditionsModule.conditions)
  • Metabolic Disease (protocolSection.conditionsModule.conditions)
  • Aphasia (protocolSection.conditionsModule.conditions)
  • Speech Disorders (protocolSection.conditionsModule.conditions)
  • Language Disorders (protocolSection.conditionsModule.conditions)
  • Communication Disorders (protocolSection.conditionsModule.conditions)
  • Neurobehavioral Manifestations (protocolSection.conditionsModule.conditions)
  • Neurologic Manifestations (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.